Predictors and outcomes of scleroderma renal crisis: The High-Dose Versus Low-Dose D-Penicillamine in early diffuse systemic sclerosis trial

Arthritis and Rheumatism

Volumn 46, Issue 11, 2002, Pages 2983-2989

  DeMarco, Paul J ^a   Weisman, Michael H ^b   Seibold, James R ^c   Furst, Daniel E ^d   Wong, Weng Kee ^e   Hurwitz, Eric L ^e   Mayes, Maureen ^f   White, Barbara ^g   Wigley, Fredrick ^h   Barr, Walter ⁱ   Moreland, Larry ^j   Medsger Jr , Thomas A ^k   Steen, Virginia ^l   Martin, Richard W ^m   Collier, David ⁿ   Weinstein, Arthur ^o   Lally, Edward ^p   Varga, John ^q   Weiner, Steven R ^d   Andrews, Brian ^r   Abeles, Micha ^s   Clements, Philip J ^d   more..

^a MARSHFIELD CLINIC   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^m MICHIGAN STATE UNIVERSITY   (United States)

ⁿ UNIVERSITY OF COLORADO   (United States)

^o GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^p BROWN UNIVERSITY   (United States)

^q UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PENICILLAMINE; PREDNISONE;

ADULT; AGE; ARTICLE; CARDIOMEGALY; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; ELBOW; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; JOINT CONTRACTURE; KIDNEY DISEASE; KNEE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE WEAKNESS; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RISK FACTOR; SCLERODERMA; SEX DIFFERENCE; SKINFOLD THICKNESS; SURVIVAL; SYSTEMIC SCLEROSIS; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT PLANNING; WRIST;

ADULT; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PENICILLAMINE; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 0036845156     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10589     Document Type: Article

References (10)

1. Steen VD. Organ involvement: Renal. In: Clements PJ, Furst DE, editors. Systemic Sclerosis. Baltimore: Williams and Wilkins; 1996. p. 425-40.
2. Steen VD, Medsger TA Jr, Osial TA, Ziegler GL, Shapiro AP, Rodnan GP. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 1984;76:779-86.
3. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990;113:352-7.
4. Steen VD, Medsger TA Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998;41:1613-9.
5. Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial. Arthritis Rheum 2000;43:2445-54.
6. Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 1999;42:1194-203.
7. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
8. Nagelkerke NJD. A note on a generalized definition of the coefficient of determination. Biometrika 1991;78:691-2.
9. Giersson AJ, Wollheim FA, Akesson A. Disease severity of 100 patients with systemic sclerosis over a period of 14 years: Using a modified Medsger scale. Ann Rheum Dis 2001;60:1117-22.
10. Lunseth JH, Baker LA, Shifrin A. Chronic scleroderma with acute exacerbation during corticotropin therapy. Arch Intern Med 1951;88:783-92.